Navigation Links
Lupus Research Institute Awards $3.6 Million for Novel Studies Driving Wide-Ranging New Science in Lupus
Date:2/15/2012

NEW YORK, Feb. 15, 2012 /PRNewswire/ -- The Lupus Research Institute (LRI) today awards 12 "Novel Research Grants" to jumpstart discovery in lupus by supporting original, highly promising ideas from some of the country's most creative scientists. Studies will look at why lupus turns the body's immune system against itself and pioneer strategies for new treatment development.   

The new awards represent diverse disciplines, from inflammation and medical imaging to evolutionary biology and the emerging field of epigenetics, bringing new talent and new approaches to lupus. Rigorous peer-review of 106 applications involved LRI's scientific advisors and over 90 lupus experts nationwide; $3.6 million was granted. Award-winning projects represent the best of the best, with potential to achieve significant results and accelerate drug discovery.

"What distinguishes the Lupus Research Institute is our insistence on funding only novel ideas rather than furthering established concepts," said Margaret Dowd, LRI President and CEO. "Our success in delivering pivotal discoveries proves that openness to inventive science works. As one advisor eloquently noted, 'great science cannot be managed; it must be imagined.'"

Championing human lupus biology, the LRI aims to speed the pace of meaningful findings in the human disease, providing fresh insights to directly inform new treatment and diagnostic development. Six investigators will work directly with patients using their blood cells, genetic information, and brain images to ask fundamental questions about the lupus immune system previously only approached in animal models.

"The Lupus Research Institute is uniquely positioned to identify novel high-risk projects that offer great return for the lupus community," noted world-leading immunologist Dr. William Paul, LRI Scientific Advisory Board Chairman and Nati
'/>"/>

SOURCE Lupus Research Institute
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Trubion Pharmaceuticals, Inc. Announces Initiation of Phase 1 Study of SBI-087 for the Treatment of Systemic Lupus Erythematosus (SLE)
2. Human Genome Sciences Reports Positive Long-Term Data for BENLYSTA(TM) (Formerly LymphoStat-B(R)) in Patients With Active Systemic Lupus Erythematosus
3. Human Genome Sciences to Host July 20 Conference Call to Discuss Top-Line Phase 3 Results for Benlysta(TM) (Formerly Lymphostat-B(R)) in Systemic Lupus Erythematosus
4. Biologic Agents Will Drive the Systemic Lupus Erythematosus Drug Market to More Than Quadruple to Nearly $2 Billion in 2018
5. Promise of a New Lupus Treatment Is a Groundbreaking Achievement
6. Lupus Research Institute: Benlysta(TM) Trial Results in an Historic Research Breakthrough and Victory for People With Lupus
7. deCODE Announces Agreement With Pfizer to Search for Variants in the Human Genome That Confer Risk of Systemic Lupus Erythematosis
8. Systemic Lupus Erythematosus Therapeutics (SLE) - Pipeline Assessment and Market Forecasts to 2018
9. Human Genome Sciences Europe Moves to the Cloud With Veeva CRM to Support New Lupus Treatment
10. Exagen Diagnostics Launches Cutting-Edge Lupus Diagnostic
11. NIH Funds $1M Research at Quest Product Development and University of Colorado for New Digitally-Controlled Endoscopes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... IL (PRWEB) January 15, 2014 Look ... find hard-working items for the lab, from fluid handling ... Guaranteed-in-Stock (GIS)—ready to ship when you order. , ... Peristaltic Pumps , from the L/S® model for precise ...
(Date:1/15/2014)... This webinar will focus on EMA and FDA ... biosimilars. , Regulatory frameworks are evolving many countries to ... complex nature of biopharmaceuticals makes the demonstration of biosimilarity ... Based on the specific aspects of biosimilar drug development ...
(Date:1/15/2014)... The Microcompetition with Foreign DNA theory explains ... these latent viruses is the Epstein Barr Virus (EBV), and ... (RA) is a chronic inflammatory disease that destroys the body’s ... RA patients have high concentrations of EBV DNA in their ...
(Date:1/15/2014)... January 15, 2014 AudioNotch is the ... therapy for the treatment of tinnitus. Patients listen to ... and over a period of weeks to months, their tinnitus ... in two forms: Notched Music and Notched White Noise. Now, ...
Breaking Biology Technology:Cole-Parmer Begins 2014 with the Release of Preferred Solutions 2Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3
... - Oncolytics Biotech Inc.,("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced ... pursue a pivotal (Phase II/III) randomized trial ... refractory,patients with head and neck cancers. The ... by the Company,s Board of Directors from ...
... team up in specialty biologics development, TORONTO ... and,Therapure BioPharma Inc. have agreed to partner in ... for cancer treatments, with a goal of,advancing the ... a,marketing partner to add to its portfolio of ...
... deCODE,genetics (Nasdaq: DCGN ) today announced today that ... Qualifications Panel to present a plan for,regaining compliance ... market value of listed securities of $50 million. ... Letter from The,Nasdaq Stock Market LLC indicating that ...
Cached Biology Technology:Oncolytics Biotech Inc. Announces Decision to Pursue Phase II/III Pivotal Clinical Trial 2Therapure Biopharma Inc. announces collaboration with BioVectra Inc. 2deCODE Requests Hearing With Nasdaq Following Receipt of Staff Determination Letter 2deCODE Requests Hearing With Nasdaq Following Receipt of Staff Determination Letter 3deCODE Requests Hearing With Nasdaq Following Receipt of Staff Determination Letter 4
(Date:4/17/2014)... RIVERSIDE, Calif. One day about eight years ago, ... of California, Riverside, and her father were on a field ... stumbled upon an orchid they had never seen before. , ... authority on orchids. The orchid turned out to be ... Silveras: Lophiaris silverarum . , "Lophiaris" is the genus ...
(Date:4/17/2014)... in France have hit on a novel method ... the correct and most effective treatment possible., Kidney ... western and developing world. If left untreated, apart ... renal failure and other complications. In many patients ... Clearly a more effective pathological approach to diagnosis ...
(Date:4/17/2014)... whereby the genetic information of DNA is used ... have numerous different functions in living organisms. Messenger ... gene expression, by relating the genetic information of ... proteins. , By examining the different types ... organism at a given time, researchers can determine ...
Breaking Biology News(10 mins):Orchid named after UC Riverside researcher 2Orchid named after UC Riverside researcher 3Rapid and accurate mRNA detection in plant tissues 2
... discovery by researchers at Oregon State University, the world,s multi-billion ... This industry, that produces metal castings used in everything from ... dates back thousands of years to before Greek and Roman ... but still continues to evolve. Some modern technologies use ...
... sites across the U.S. have contaminated groundwater that requires remediation, ... meaning restoration is unlikely to be achieved in the next ... new report from the National Research Council. The report ... sites ranges from $110 billion to $127 billion, but the ...
... becomes increasingly important to know in detail the dynamics of ... of a millimeter). What happens, for example, when we try ... molecules, such as DNA) through a nanopore if knots cause ... because now a new DNA sequencing method to electrochemically analyze ...
Cached Biology News:Sweet new approach discovered to help produce metal casting parts, reduce toxicity 2Report: Cleanup of some contaminated groundwater sites unlikely for decades 2Report: Cleanup of some contaminated groundwater sites unlikely for decades 3Pull with caution 2
Although each Beacon 2000 System includes one preinstalled sample chamber (size specified at time of order), optional chambers are available and easily retrofit by the user....
... Immunogen : Recombinant human ... 5mg/ml BSA, 0.15M NaCl, 0.05% ... of glycerol to 30% Quality ... on acid extracts of murine ...
cDNA Size Fractionation Columns offer an efficient and convenient method for size-fractioning double-stranded cDNA....
Self Closing Forceps...
Biology Products: